Company / Cash per Share
Merck & Co. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$5.72
FY2025
5-year range
$2.70 / $5.72
FY2021-FY2025
Trend
+9.8%
vs FY2024
Sector context
#37 of 205
Health Care
What the data says
Merck & Co.'s cash per share of $5.72 is higher than 82% of companies in the Health Care sector (FY2025). Cash per Share has fluctuated over the past 10 years, ranging from $2.14 in FY2017 to $5.72 in FY2025.
Based on SEC 10-K filings.
5.72 in FY2025 with a 5-year CAGR of +13.7%. Top quartile in the Health Care sector.
Improved from $2.70 to $5.72 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +4.6%
- 5-Year CAGR
- +13.7%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 205This company $5.72 Sector average $72.93
▼
-92.2% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 9.8% year-over-year.
- Ranks #37 out of 205 companies in the Health Care sector.
- Lowest cash per share in the period was in FY2017.
Company context
Key Data Points
- Strong profit margin: 29.6%
- Strong return on equity: 36.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.72 | +9.8% |
| FY2024 | $5.21 | +93.3% |
| FY2023 | $2.70 | -46.0% |
| FY2022 | $5.00 | +59.2% |
| FY2021 | $3.14 | +4.4% |
| FY2020 | $3.00 | -14.7% |
| FY2019 | $3.52 | +23.2% |
| FY2018 | $2.86 | +33.3% |
| FY2017 | $2.14 | -3.6% |
| FY2016 | $2.23 | -21.8% |
As of FY2025 · SEC 10-K · Updated Mar 9, 2026